| Security Name | Ticker | % of Net Assets |
|---|---|---|
| ABBVIE INC | ABBV | 7.37% |
| AMGEN INC | AMGN | 5.07% |
| GILEAD SCIENCES INC | GILD | 4.69% |
| VERTEX PHARMACEUTICALS INC | VRTX | 3.93% |
| REGENERON PHARMACEUTICALS INC | REGN | 2.99% |
| REVOLUTION MEDICINES INC | RVMD | 2.70% |
| BEONE MEDICINES LTD | ONC | 2.41% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | 2.39% |
| ROYALTY PHARMA PLC | RPRX | 2.23% |
| NATERA INC | NTRA | 2.15% |
| BIOGEN INC | BIIB | 2.10% |
| ILLUMINA INC | ILMN | 2.06% |
| UNITED THERAPEUTICS CORP | UTHR | 1.99% |
| JAZZ PHARMACEUTICALS PLC | JAZZ | 1.87% |
| VIATRIS INC | VTRS | 1.85% |
| GUARDANT HEALTH INC | GH | 1.82% |
| ARGENX SE | ARGX | 1.81% |
| NEUROCRINE BIOSCIENCES INC | NBIX | 1.69% |
| INSMED INC | INSM | 1.66% |
| INCYTE CORP | INCY | 1.63% |
| ROIVANT SCIENCES LTD | ROIV | 1.58% |
| ASTRAZENECA PLC | AZN | 1.56% |
| ALKERMES PLC | ALKS | 1.55% |
| MODERNA INC | MRNA | 1.55% |
| EXELIXIS INC | EXEL | 1.51% |
| ARROWHEAD PHARMACEUTICALS INC | ARWR | 1.49% |
| AXSOME THERAPEUTICS INC | AXSM | 1.43% |
| IONIS PHARMACEUTICALS INC | IONS | 1.41% |
| BRIDGEBIO PHARMA INC | BBIO | 1.41% |
| CYTOKINETICS INC | CYTK | 1.41% |
| BIOMARIN PHARMACEUTICAL INC | BMRN | 1.20% |
| CRISPR THERAPEUTICS AG | CRSP | 1.20% |
| HALOZYME THERAPEUTICS INC | HALO | 1.16% |
| TG THERAPEUTICS INC | TGTX | 1.15% |
| MEDPACE HOLDINGS INC | MEDP | 1.14% |
| ASCENDIS PHARMA A/S | ASND | 1.11% |
| BIONTECH SE | BNTX | 1.10% |
| LIQUIDIA CORP | LQDA | 1.03% |
| TRAVERE THERAPEUTICS INC | TVTX | 1.01% |
| PTC THERAPEUTICS INC | PTCT | 0.99% |
| MIRUM PHARMACEUTICALS INC | MIRM | 0.98% |
| VAXCYTE INC | PCVX | 0.93% |
| SCHOLAR ROCK HOLDING CORP | SRRK | 0.92% |
| VERACYTE INC | VCYT | 0.90% |
| MADRIGAL PHARMACEUTICALS INC | MDGL | 0.89% |
| TWIST BIOSCIENCE CORP | TWST | 0.88% |
| PROTAGONIST THERAPEUTICS INC | PTGX | 0.85% |
| COGENT BIOSCIENCES INC | COGT | 0.85% |
| RHYTHM PHARMACEUTICALS INC | RYTM | 0.82% |
| CELCUITY INC | CELC | 0.82% |
| APOGEE THERAPEUTICS INC | APGE | 0.74% |
| LEGEND BIOTECH CORP | LEGN | 0.73% |
| KYMERA THERAPEUTICS INC | KYMR | 0.70% |
| NUVALENT INC | NUVL | 0.69% |
| VIKING THERAPEUTICS INC | VKTX | 0.67% |
| BEAM THERAPEUTICS INC | BEAM | 0.66% |
| GRAIL INC | GRAL | 0.65% |
| ACADIA PHARMACEUTICALS INC | ACAD | 0.65% |
| SUMMIT THERAPEUTICS INC | SMMT | 0.64% |
| ULTRAGENYX PHARMACEUTICAL INC | RARE | 0.60% |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.58% |
| KRYSTAL BIOTECH INC | KRYS | 0.56% |
| PRAXIS PRECISION MEDICINES INC | PRAX | 0.55% |
| SAREPTA THERAPEUTICS INC | SRPT | 0.51% |
| RECURSION PHARMACEUTICALS INC | RXRX | 0.49% |
| INTELLIA THERAPEUTICS INC | NTLA | 0.46% |
| ADMA BIOLOGICS INC | ADMA | 0.42% |
| AKERO THERAPEUTICS INC | AKRO | 0.00% |
| Other (Cash, derivatives and other liabilities) | 0.46% | |
| Total: | ||
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Private Investments, LLC, Guggenheim Investments Loan Advisors, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.